Reports

Drug name	NICE TAs	Comments
Fluocinolone acetonide intravitreal implant (Illuvien®)	TA301 - Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after an inadequate response to prior therapy TA590 - Fluocinolone acetonide intravitreal implant for treating recurrent non-infectious uveitis TA953 - Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema
Fluorouracil injection	TA212 - Bevacizumab in combination with oxaliplatin and either fluorouracil plus folinic acid or capecitabine for the treatment of metastatic colorectal cancer TA307 - Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy	For hospital use only
Foslevodopa–foscarbidopa (Produodopa®)	TA934: Foslevodopa–foscarbidopa for treating advanced Parkinson’s with motor symptoms
Fostamatinib (Tavlesse®)	TA835: Fostamatinib for treating refractory chronic immune thrombocytopenia
Fremanezumab (Ajovy®)	Fremanezumab for preventing migraine (TA764)
Fucibet cream	TA81 - Frequency of application of topical corticosteroids for atopic eczema	Steroid potency - potent
Fucidin H cream	TA81 - Frequency of application of topical corticosteroids for atopic eczema	Mild potency
Galantamine M/R capsules	TA217 - Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease	Dementia drugs ESCA
Galantamine solution	TA217 - Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease	Dementia drugs ESCA
Galantamine tablets	TA217 - Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease	Dementia drugs ESCA

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
Next page
Last page

University Hospitals Birmingham NHS Foundation Trust

Medicines Formulary

Reports